Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.95M | -459.70K | -488.50K | -523.50K | 369.60K |
| Total Depreciation and Amortization | 2.40K | 2.50K | 26.00K | 25.70K | 25.60K |
| Total Amortization of Deferred Charges | 70.90K | 61.30K | 79.20K | 81.30K | 68.80K |
| Total Other Non-Cash Items | 3.41M | -8.70K | -24.80K | 57.20K | -760.20K |
| Change in Net Operating Assets | 215.30K | 76.70K | 188.30K | 108.60K | 7.80K |
| Cash from Operations | -251.20K | -327.80K | -219.80K | -250.80K | -288.40K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | -25.00K |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -25.00K |
| Total Debt Issued | 352.60K | 447.70K | 328.00K | 288.60K | 525.40K |
| Total Debt Repaid | -123.30K | -110.20K | -99.60K | -113.30K | -146.80K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 229.40K | 337.50K | 228.40K | 175.30K | 378.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.80K | 9.70K | 8.60K | -75.50K | 65.20K |